Search results
Results from the WOW.Com Content Network
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on ...
SOM Innovation Biotech, S.A. (SOM Biotech), is a private pharmaceutical company focused on the accelerated discovery and development of therapies for orphan diseases through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies.
WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing ...
The Biotechnology Innovation Organization (BIO), a Washington-based trade association representing biotechnology companies in the U.S. and more than 30 other countries, including WuXi AppTec, had ...
Apart from the nearly 70,000 New Jerseyans directly employed by the biotech industry, an additional 212,000 hold jobs that are indirectly supported by life sciences. Biotech R&D jobs are also ...
By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for initial funding to create biotechnology startups at the Alexandria Center for Life Science, which encompasses more than 700,000 square feet (65,000 m 2) on East 29th Street ...
Gary Kaufman, ABI-LAB's chief operating officer, recently hosted a tour of the Strathmore Road facility, called ABI-LAB 2, to the Daily News, laying out the biotech lab space's plans for expansion.
John Francis Crowley (born April 7, 1967) is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. [1] He served as the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme ...